Generic Industry Hit With Avalanche Of Price Fixing Suits
Executive Summary
As state attorneys general and Department of Justice move against generic manufacturers, plaintiffs’ firms have filed more than 90 antitrust suits on behalf of third party payers.
You may also be interested in...
Heritage Is First To Settle DOJ Generic Drug Price Fixing Probe
Heritage agrees to pay $7.1m to resolve civil allegations and a $225,000 criminal penalty. DOJ defers prosecution of one felony charge.
Heritage Is First To Settle DOJ Generic Drug Price Fixing Probe; Will Others Follow?
Heritage agrees to pay $7.1m to resolve civil allegations and a $225,000 criminal penalty. DOJ defers prosecution of one felony charge.
Government Pharma Investigations Target Pricing, Opioids, Trade Practices
While DOJ probes have declined in last few years, 13 of top 25 pharma companies are dealing with ongoing inquiries of marketing and pricing practices.